Kwok-kin Wong

Cancer Discovery · 2007–2018

A researcher in the Science corpus: 23 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Kwok-kin Wong trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Randy J. Read (in Computational Theory and Mathematics)

Papers from Kwok-kin Wong's perspective

Ordered by how strongly the researchers Kwok-kin Wong trusts endorse each paper. Same corpus, a different order for every researcher.

  1. EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy (Science)
  2. Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
  3. Refinement of macromolecular structures by the maximum-likelihood method.
  4. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. (Proceedings of the National Academy of Sciences of the United States of America)
  5. KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib (PLoS Medicine)
  6. Targeting polo-like kinase 1 for cancer therapy (Nature Reviews. Cancer)
  7. Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor* (Journal of Biological Chemistry)
  8. Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction (Cell)
  9. Multiple BCR-ABL kinase domain mutations confer polyclonal resistance to the tyrosine kinase inhibitor imatinib (STI571) in chronic phase and blast crisis chronic myeloid leukemia. (Cancer Cell)
  10. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. (Cell)

Their papers